Box office for Spider-Man: Brand New Day posted a global opening of $927 million, signaling strong theater attendance and demand for premium formats. Dolby Cinema and other premium formats dominated weekend receipts, highlighting potential tailwinds for Dolby Laboratories (DLB) if this momentum extends into August. The trend points to a healthier cinema equipment cycle in the near term.
High implied volatility in DLB options indicates expected significant price movement. Zacks Rank for DLB is #4 (Sell), suggests a bearish outlook. Earnings estimates for DLB decreased from 67 cents to 59 cents per share.
- Dolby reported revenue of $364.52 million, down 3% from last year. EPS was $1.27. - Revenue beat the Zacks Consensus Estimate by 0.70%, EPS beat by 8.55%. - Metrics like revenue from products/services and licensing saw changes over the year. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings
- Dolby Laboratories earnings beat estimates with $1.27 per share, surpassing last year's $1.26. - The company posted revenues of $364.52 million, exceeding expectations by 0.70%. - Dolby Laboratories shares have lost 10% year-to-date, while S&P 500 gained 5.2%. Price Impact Rating: bearish Impact Horizon Rating: short-term Type: Earnings
- Analysts expect DLB to post $1.17 EPS, a 7.1% YoY decline, and $361.98 million in revenue, down 3.7%. - Consensus EPS estimate unchanged in the past 30 days, indicating analysts' reassessment. - Earnings estimate revisions crucial before company's announcement, significant for potential investor actions. - Wall Street analysts predict 'Revenue- Products and services' up 7.3%, 'Revenue- Licensing' down 4.5%. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Research Analysis